ORIGINAL RESEARCH
Accepted on 09 Jul 2025
L1, a 3,3'-Diindolylmethane-derivative, induced ER stress-mediated apoptosis and suppressed growth through the FLI1/AKT pathway in erythroleukemia HEL cells
doi 10.3389/fphar.2025.1564199
- Frontiers in Medicine
- Gene and Cell Therapy
- Research Topics
- Exploiting Biomarkers for Targeted Therapies in Acute Myeloid Leukemia
Exploiting Biomarkers for Targeted Therapies in Acute Myeloid Leukemia
1,101
Total downloads
5,032
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 21 Mar 2025
Identifying acute myeloid leukemia subtypes based on pathway enrichment
doi 10.3389/fphar.2025.1557112
- 1,094 views
ORIGINAL RESEARCH
Published on 28 Feb 2024
A hypoxia-related genes prognostic risk model, and mechanisms of hypoxia contributing to poor prognosis through immune microenvironment and drug resistance in acute myeloid leukemia
doi 10.3389/fphar.2024.1339465
- 2,312 views
- 2 citations
Published in
Frontiers in Medicine
Gene and Cell Therapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Frontiers in Pharmacology
- 4.8 impact factor
- 8.9 citescore